Document Detail


Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
MedLine Citation:
PMID:  21610723     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Great uncertainty exists as to whether aging enhances the detrimental effects of tissue plasminogen activator (tPA) on vascular integrity of the ischemic brain. We hypothesized that tPA treatment would augment ischemic injury by causing increased blood-brain barrier (BBB) breakdown as determined by quantitative serial T(1) and T(2) magnetic resonance imaging (MRI), and the transfer constant for gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA) from blood to brain in aged (18 to 20 months) compared with young (3 to 4 months) Wistar rats after middle cerebral artery occlusion, mediated through the acute disassembly of claudin 5 and occludin. Increased T(2) values over the first hour of postreperfusion were independently augmented following treatment with tPA (P<0.001) and aging (P<0.01), supporting a synergistic effect of tPA on the aged ischemic brain. Blood-brain barrier permeability for Gd-DTPA (K(Gd)) was substantial following reperfusion in all animal groups and was exacerbated by tPA treatment in the elderly rat (P<0.001). The frequency of hematoma formation was proportionately increased in the elderly ischemic brain (P<0.05). Both tPA and age independently increased claudin 5 and occludin phosphorylation during ischemia. Early BBB permeability detected by quantitative MRI following ischemic stroke is enhanced by increased age and tPA and is related to claudin 5 and occludin phosphorylation.
Authors:
Jaspreet Kaur; Ursula I Tuor; Zonghang Zhao; Philip A Barber
Related Documents :
19794323 - The effect of blood transfusion on brain oxygenation in children with severe traumatic ...
3612573 - Contraction of human umbilical artery, but not vein, by oxygen.
19195933 - Parasympathetic tonic dilatory influences on cerebral vessels.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-05-25
Journal Detail:
Title:  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism     Volume:  31     ISSN:  1559-7016     ISO Abbreviation:  J. Cereb. Blood Flow Metab.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-02     Completed Date:  2011-10-27     Revised Date:  2011-11-02    
Medline Journal Info:
Nlm Unique ID:  8112566     Medline TA:  J Cereb Blood Flow Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1874-85     Citation Subset:  IM    
Affiliation:
Department of Clinical Neurosciences, Experimental Imaging Centre and Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aging
Animals
Blood-Brain Barrier / drug effects*,  metabolism,  pathology
Brain / drug effects*,  metabolism,  pathology
Brain Ischemia / drug therapy*,  metabolism,  pathology
Fibrinolytic Agents / pharmacology,  therapeutic use*
Infarction, Middle Cerebral Artery / drug therapy,  metabolism,  pathology
Magnetic Resonance Imaging
Male
Membrane Proteins / metabolism*
Permeability / drug effects
Rats
Rats, Wistar
Tissue Plasminogen Activator / pharmacology,  therapeutic use*
Grant Support
ID/Acronym/Agency:
//Canadian Institutes of Health Research
Chemical
Reg. No./Substance:
0/Cldn5 protein, rat; 0/Fibrinolytic Agents; 0/Membrane Proteins; 0/occludin; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP rece...
Next Document:  A novel methodology for large-scale phylogeny partition.